These objectives are based on data and assumptions that the group considers reasonable. These objectives depend on conditions or facts that are likely to occur in the future and not exclusively on historical data. Given the emergence of certain risks and uncertainties, actual results may differ materially from these objectives, in particular because a promising product can never be placed on the market at the early stage of development or clinical trial, nor can it achieve its commercial objectives, including for regulatory or competitive reasons. The group faces or could face competition from generic drugs, which could lead to a loss of market share.